Related references
Note: Only part of the references are listed.Efficacy and Effectiveness of Artemether-Lumefantrine after Initial and Repeated Treatment in Children < 5 Years of Age with Acute Uncomplicated Plasmodium falciparum Malaria in Rural Tanzania: A Randomized Trial
Billy E. Ngasala et al.
CLINICAL INFECTIOUS DISEASES (2011)
A thirteen-year analysis of Plasmodium falciparum populations reveals high conservation of the mutant pfcrt haplotype despite the withdrawal of chloroquine from national treatment guidelines in Gabon
Matthias Frank et al.
MALARIA JOURNAL (2011)
Efficacy and safety of a fixed-dose oral combination of pyronaridine-artesunate compared with artemether-lumefantrine in children and adults with uncomplicated Plasmodium falciparum malaria: a randomised non-inferiority trial
Antoinette K. Tshefu et al.
LANCET (2010)
Therapeutic efficacy of Artemether/Lumefantrine (Coartem®) against Plasmodium falciparum in Kersa, South West Ethiopia
Ashenafi Assefa et al.
PARASITES & VECTORS (2010)
Artemisinin Directly Targets Malarial Mitochondria through Its Specific Mitochondrial Activation
Juan Wang et al.
PLOS ONE (2010)
Artemisinin Resistance in Plasmodium falciparum Malaria.
Arjen M. Dondorp et al.
NEW ENGLAND JOURNAL OF MEDICINE (2009)
Malaria genomics meets drug-resistance phenotyping in the field
Paul Hunt et al.
GENOME BIOLOGY (2009)
Effectiveness of quinine versus artemether-lumefantrine for treating uncomplicated falciparum malaria in Ugandan children: randomised trial
Jane Achan et al.
BMJ-BRITISH MEDICAL JOURNAL (2009)
Changes in malaria indices between 1999 and 2007 in The Gambia: a retrospective analysis
Serign J. Ceesay et al.
LANCET (2008)
Effect of a fall in malaria transmission on morbidity and mortality in Kilifi, Kenya
Wendy P. O'Meara et al.
LANCET (2008)
Gene encoding a deubiquitinating enzyme is mutated in artesunate- and chloroquine-resistant rodent malaria parasites
Paul Hunt et al.
MOLECULAR MICROBIOLOGY (2007)
The role of pfmdr1 in Plasmodium falciparum tolerance to artemether-lumefantrine in Africa
Christin Sisowath et al.
TROPICAL MEDICINE & INTERNATIONAL HEALTH (2007)
Return of chloroquine antimalarial efficacy in Malawi
Miriam K. Laufer et al.
NEW ENGLAND JOURNAL OF MEDICINE (2006)
Duration of protection with RTS,S/AS02A malaria vaccine in prevention of Plasmodium falciparum disease in Mozambican children:: single-blind extended follow-up of a randomised controlled trial
PL Alonso et al.
LANCET (2005)
A single amino acid residue can determine the sensitivity of SERCAs to artemisinins
AC Uhlemann et al.
NATURE STRUCTURAL & MOLECULAR BIOLOGY (2005)
Efficacy and safety of artemether-lumefantrine (Coartem®) tablets (six-dose regimen) in African infants and children with acute) uncomplicated falcipaurum malaria
C Falade et al.
TRANSACTIONS OF THE ROYAL SOCIETY OF TROPICAL MEDICINE AND HYGIENE (2005)
In vivo selection of Plasmodium falciparum pfmdr1 86N coding alleles by artemether-lumefantrine (Coartem)
C Sisowath et al.
JOURNAL OF INFECTIOUS DISEASES (2005)
Reemergence of chloroquine-sensitive Plasmodium falciparum malaria after cessation of chloroquine use in Malawi
JG Kublin et al.
JOURNAL OF INFECTIOUS DISEASES (2003)
A molecular marker for chloroquine-resistant falciparum malaria
A Djimdé et al.
NEW ENGLAND JOURNAL OF MEDICINE (2001)
The tyrosine-86 allele of the pfmdr1 gene of Plasmodium falciparum is associated with increased sensitivity to the anti-malarials mefloquine and artemisinin
MT Duraisingh et al.
MOLECULAR AND BIOCHEMICAL PARASITOLOGY (2000)
Share Paper
